Proteogenomic and metabolomic characterization of human glioblastoma

Wang, Liang-Bo, Karpova, Alla, Gritsenko, Marina A., Kyle, Jennifer E., Cao, Song, Li, Yize, Rykunov, Dmitry, Colaprico, Antonio +230 more·2021·Cancer Cell

DOI 10.1016/j.ccell.2021.01.006

Cited by (656)

Items 101–200 of 656

Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated
Keywan Mortezaee, Jamal Majidpoor, Ebrahim Kharazinejad · 2022 · Medical Oncology
The relationship between radiomics and pathomics in Glioblastoma patients: Preliminary results from a cross-scale association study
Valentina Brancato, Carlo Cavaliere, Nunzia Garbino, Francesco Isgrò, Marco Salvatore, Marco Aiello · 2022 · Frontiers in Oncology
Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients
Tianwen Li, Zhipeng Yang, Haoyuan Li, Jingjing Zhu, Ye Wang, Qisheng Tang, Zhifeng Shi · 2021 · Laboratory Investigation
Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting
Wanshan Liu, Yingxiu Luo, Jingjing Dai, Ludi Yang, Lin Huang, Ruimin Wang, Wei Chen, Yida Huang, Shiyu Sun, Jing Cao et al. · 2021 · Small Methods
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
Bakas, Spyridon, Vollmuth, Philipp, Galldiks, Norbert, Booth, Thomas C, Aerts, Hugo J W L, Bi, Wenya Linda, Wiestler, Benedikt, Tiwari, Pallavi, Pati, Sarthak, Baid, Ujjwal et al. · 2024 · The Lancet Oncology
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
Tzu‐Jen Kao, Chien-Liang Lin, Wen‐Bin Yang, Hao‐Yi Li, Tsung‐I Hsu · 2023 · Lipids in Health and Disease
Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production
Mingliang Chen, Ying He, Xunhu Dong, Hao-Fei Liu, Zexuan Yan, Xiao-Lu Lu, Qing-Qing Miao, Qingning Zhao, Hang Zhang, Li Luo et al. · 2025 · Cancer Cell
TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO
Yike Chen, Xiaohui Xu, Kaikai Ding, Tianchi Tang, Feng Cai, Haocheng Zhang, Zihang Chen, Yangjian Qi, Zaixiang Fu, Ganggui Zhu et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
Trang T.T. Nguyen, Enyuan Shang, Salveena Schiffgens, Consuelo Torrini, Chang Shu, Hasan Orhan Akman, Varun V. Prabhu, Joshua E. Allen, Mike-Andrew Westhoff, Georg Karpel-Massler et al. · 2022 · Clinical Cancer Research
Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners
Himangi Srivastava, Michael J. Lippincott, Jordan Currie, Robert Canfield, Maggie P. Y. Lam, Edward Lau · 2022 · PLoS Computational Biology
Functional Impact of Protein–RNA Variation in Clinical Cancer Analyses
Gali Arad, Tamar Geiger · 2023 · Molecular & Cellular Proteomics
Proteogenomics-based functional genome research: approaches, applications, and perspectives in plants
Yu‐Chen Song, Debatosh Das, Youjun Zhang, Mo‐Xian Chen, Alisdair Robert Fernie, Fu‐Yuan Zhu, Jiangang Han · 2023 · Trends in biotechnology
Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy
Song Yang, Yumeng Sun, Wei Liu, Yi qin Zhang, Guozhu Sun, Bai Xiang, Jiankai Yang · 2024 · Cancers
Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
Maowu Fu, Bing Xue, Xiuming Miao, Zong Gao · 2025 · Frontiers in Pharmacology
Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction
Natalia Di Ianni, Silvia Musio, Serena Pellegatta · 2021 · International Journal of Molecular Sciences
Phase 2 of extracellular RNA communication consortium charts next-generation approaches for extracellular RNA research
Bogdan Mateescu, Jennifer Clare Jones, Roger P. Alexander, Eric B. Alsop, Ji Yeong An, Mohammad H. Asghari, Alex C. Boomgarden, Laura Bouchareychas, Alfonso Cayota, Hsueh‐Chia Chang et al. · 2022 · iScience
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions
Marcel Bühler, Xiao Yi, Weigang Ge, Peter Blattmann, Elisabeth Jane Rushing, Guido Reifenberger, Joerg Felsberg, Charles D. Yeh, Jacob E. Corn, Luca Regli et al. · 2022 · Neuro-Oncology
Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes
Ting‐Ting Gong, Shuang Guo, Fang-Hua Liu, Yun-Long Huo, Meng Zhang, Yan Shi, Hanxiao Zhou, Pan Xu, Xinyue Wang, He-Li Xu et al. · 2023 · Nature Communications
Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition
Can Xu, Pengyu Hou, Xiang Li, Menglin Xiao, Ziqi Zhang, Ziru Li, Jianglong Xu, Guoming Liu, Yanli Tan, Chuan Fang · 2024 · Cancer Biology and Medicine
CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis
Huihui Zhu, Qiuhong Liu, Qinna Meng, Lingjian Zhang, Siwei Ju, Jiaheng Lang, Danhua Zhu, Yongxia Chen, Nadire Aishan, Xiaoxi Ouyang et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance
Simona D’Aprile, Simona Denaro, Anna Gervasi, Nunzio Vicario, Rosalba Parenti · 2025 · Frontiers in Cell and Developmental Biology
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study
Dongjiang Chen, Son B Le, Ashley Parham Ghiaseddin, Harshit Manektalia, Ming Li, Adam O’Dell, Maryam Rahman, David Dinh Tran · 2025 · Med
Comprehensive evaluation of phosphoproteomic-based kinase activity inference
Sophia Müller‐Dott, Eric J. Jaehnig, Khoi Pham Munchic, Wen Jiang, Tomer M. Yaron, Sara R. Savage, Martín Garrido‐Rodríguez, Jared Lee Johnson, Alessandro Lussana, Evangelia Petsalaki et al. · 2025 · Nature Communications
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Nazanin Tatari, Shahbaz Khan, Julie M. Livingstone, Kui Zhai, Dillon McKenna, Vladimir Ignatchenko, Chirayu Chokshi, William D. Gwynne, Manoj Pratap Singh, Spencer D. Revill et al. · 2022 · Acta Neuropathologica
Mass Spectrometry–Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine
Sunil Kumar Joshi, Paul Piehowski, Tao Liu, Sara J.C. Gosline, Jason McDermott, Brian J. Druker, Elie A. Traer, Jeffrey W Tyner, Anupriya Agarwal, Cristina E. Tognon et al. · 2023 · The Annual Review of Pharmacology and Toxicology
Decoding heterogeneous and coordinated tissue architecture in glioblastoma using spatial transcriptomics
Xuejiao Lv, Bo Wang, Kunlun Liu, Mulin Jun Li, Xianfu Yi, Xudong Wu · 2024 · iScience
A nuclear function for an oncogenic microRNA as a modulator of snRNA and splicing
Rachid El Fatimy, Yanhong Zhang, Evgeny Deforzh, Mahalakshmi Ramadas, Harini Saravanan, Zhiyun Wei, Rosalia Rabinovsky, Nadiya M. Teplyuk, Erik J. Uhlmann, Anna M. Krichevsky · 2022 · Molecular Cancer
A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells
Yu Wei Zhang, Ana Gvozdenovic, Nicola Aceto · 2024 · Cancer Discovery
Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer
Hao Hui Chen, Changqing Jing, Liang Shang, Xingyu Zhu, Ronghua Zhang, Yuan Liu, Mingfei Wang, Kang Xu, Tianrong Ma, Haiyan Jing et al. · 2024 · Cell Reports
Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes
Lingling Li, Dongxian Jiang, Hui Liu, Chunmei Guo, Rui Zhao, Qiao Zhang, Chen Xu, Zhaoyu Qin, Jinwen Feng, Yang Liu et al. · 2023 · Nature Communications
Glioma and post-translational modifications: A complex relationship
Tomasz Pienkowski, Tomasz Kowalczyk, Dominik Cysewski, Adam Jacek Kretowski, Michał Ciborowski · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes
Marco M. Buttigieg, Caitlyn Vlasschaert, Alexander G. Bick, Robert J. Vanner, Michael J. Rauh · 2025 · Cell Reports Medicine
Imaging-Genomics in Glioblastoma: Combining Molecular and Imaging Signatures
Dongming Liu, Jiu Chen, Xin‐Hua Hu, Kun Yang, Yong Liu, Guanjie Hu, Honglin Ge, Wenbin Zhang, Hongyi Liu · 2021 · Frontiers in Oncology
Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma
Jacob J. Kennedy, Jeffrey R. Whiteaker, Richard G. Ivey, Aura Burian, Shrabanti Chowdhury, Chia‐Feng Tsai, Tao Liu, Chenwei Lin, Oscar D. Murillo, Rachel A. Lundeen et al. · 2022 · Analytical Chemistry
Optimized data-independent acquisition approach for proteomic analysis at single-cell level
Yuefan Wang, T. Mamie Lih, Lijun Chen, Yuanwei Xu, Morgan D. Kuczler, Liwei Cao, Kenneth J. Pienta, Sarah R. Amend, Hui Zhang · 2022 · Clinical Proteomics
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability
Niklas Ravn-Boess, Nainita Roy, Takamitsu Hattori, Devin Bready, Hayley Donaldson, Christopher Lawson, Cathryn Lapierre, Aryeh Korman, Tori C. Rodrick, Enze Liu et al. · 2023 · Cell Reports
Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production
Evan Noch, Laura Palma, Isaiah Yim, Nayah Bullen, Daniel Barnett, Alexander Walsh, Bhavneet Bhinder, Elisa Benedetti, Jan Krumsiek, Justin Gurvitch et al. · 2024 · Proceedings of the National Academy of Sciences
It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma
Rebeca Yakubov, Ramneet Kaloti, Phooja Persaud, Anna McCracken, Gelareh Mohammed Zadeh, Severa Bunda · 2025 · Journal of Neuro-Oncology
Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights
Li Zhang, Yang Yang, Yanchu Li, Chenyu Wang, Chenbin Bian, Hongbin Wang, Feng Wang · 2025 · Biomarker Research
Liquid biopsy: creating opportunities in brain space
Trivedi, Rakesh, Bhat, Krishna P. · 2023 · British Journal of Cancer
The Comprehensive “Omics” Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy
Sang Jun Yoon, Chae-Bin Lee, Soon Uk Chae, Seongjun Jo, S. Bae · 2021 · International Journal of Molecular Sciences
Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
Rachel L. Y. Ho, Ivy A. W. Ho · 2021 · Cancers
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients
Franz Lennard Ricklefs, Richard Drexler, Kathrin Wollmann, Alicia Eckhardt, Dieter Henrik Heiland, Thomas Sauvigny, Cécile L. Maire, Katrin Lamszus, Manfred Westphal, Ulrich Schüller et al. · 2022 · Neuro-Oncology
Integrative multi-omics approach to targeted therapy for glioblastoma
Lynnette Koh, Wisna Novera, See Wee Lim, Yuk Kien Chong, Qing You Pang, David C.Y. Low, Beng Ti Ang, Carol Tang · 2022 · Pharmacological Research
Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma
Kacper Adam Walentynowicz, Dalit Engelhardt, Simona Cristea, Shreya Yadav, Ugoma Onubogu, Roberto Salatino, Melanie Maerken, Cristina Vincentelli, Aashna Jhaveri, Jacob Geisberg et al. · 2023 · Cell Reports
Aberrant MET Receptor Tyrosine Kinase Signaling in Glioblastoma: Targeted Therapy and Future Directions
Abdulhameed Al‐Ghabkari, Bruce Huang, Morag Park · 2024 · Cells
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia
James C. Pino, Camilo Posso, Sunil Kumar Joshi, Michael D. Nestor, Jamie Moon, Joshua Hansen, Chelsea M. Hutchinson-Bunch, Marina Gritsenko, Karl Weitz, Kevin Watanabe‐Smith et al. · 2024 · Cell Reports Medicine
Clinical proteomics towards multiomics in cancer
Chad J. Creighton · 2022 · Mass Spectrometry Reviews
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
Jeffrey R. Whiteaker, Rachel A. Lundeen, Lei Zhao, Regine M. Schoenherr, Aura Burian, Dongqing Huang, Uliana J. Voytovich, Tao Wang, Jacob J. Kennedy, Richard G. Ivey et al. · 2021 · Frontiers in Immunology
DIA-MS proteome analysis of formalin-fixed paraffin-embedded glioblastoma tissues
Kenneth Weke, Sachin Kote, Jakub Faktor, Sofian Al Shboul, Naomi Uwugiaren, Paul Martin Brennan, David R. Goodlett, Ted R. Hupp, Irena Đapić · 2022 · Analytica Chimica Acta
Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML
Sara J.C. Gosline, Cristina E. Tognon, Michael D. Nestor, Sunil Kumar Joshi, Rucha V. Modak, Alisa Damnernsawad, Camilo Posso, Jamie Moon, Joshua Hansen, Chelsea M. Hutchinson-Bunch et al. · 2022 · Clinical Proteomics
Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
Munazza Ahmed, Ahlam M. Semreen, Waseem El‐Huneidi, Yasser Khalil Bustanji, Eman Abu‐Gharbieh, Mohammad A. Y. Alqudah, Ahmed Alhusban, Mohd Shara, Ahmad Y. Abuhelwa, Nelson Cruz Soares et al. · 2022 · International Journal of Molecular Sciences
RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
Jiesi Zhou, Yan Shu Kong, Krista Marie Vincent, Dylan Z. Dieters‐Castator, Amirali B. Bukhari, Darryl D. Glubrecht, Rong‐Zong Liu, Douglas Quilty, Scott D. Findlay, Xiaowei Huang et al. · 2023 · Molecular Oncology
Direct image to subtype prediction for brain tumors using deep learning
Katherine Jane Hewitt, Chiara Maria Lavinia Loeffler, Hannah Sophie Muti, Anna Sophie Berghoff, Christian Eisenlöffel, Marko van Treeck, Zunamys Itzell Carrero, Omar S. M. El Nahhas, Gregory Patrick Veldhuizen, Sophie Heuer et al. · 2023 · Neuro-Oncology Advances
RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma
Xiao Song, Deanna Marie Tiek, Shunichiro Miki, Tianzhi Huang, Minghui Lu, Anshika Goenka, Rebeca Piatniczka Iglesia, Xiaozhou Yu, Runxin Wu, Maya N. Walker et al. · 2024 · Journal of Clinical Investigation
Genetic imputation of kidney transcriptome, proteome and multi-omics illuminates new blood pressure and hypertension targets
Xiaoguang Xu, Chachrit Khunsriraksakul, James Eales, Sébastien Rubin, David Scannali, Sushant Saluja, David Talavera, Havell Markus, Lida Wang, Maciej Drzal et al. · 2024 · Nature Communications
Protein-based classification reveals an immune-hot subtype in IDH mutant astrocytoma with worse prognosis
Jihong Tang, Wenhua Fan, Yuyan Ruan, Xing Liu, Fufang Qiu, Jie Feng, Guoshi Huang, Mengli Yan, Hui Wang, Quanhua Mu et al. · 2025 · Cancer Cell
Molecular landscape of IDH ‐wild type, p TERT ‐wild type adult glioblastomas
Emma Munan Liu, Zhifeng Shi, Kay Ka‐Wai Li, Tathiane Maistro Malta, Nellie Yuk‐Fei Chung, Hong Chen, Janice Yuen‐Tung Chan, Manix Fung‐Man Poon, Johnny S. H. Kwan, Danny Tat-Ming Chan et al. · 2022 · Brain Pathology
Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma
Danijela Drakulić, Marija Schwirtlich, Isidora Petrović, Marija M. Mojsin, Milena Milivojević, Nataša Kovačević‐Grujičić, Milena J. Stevanović · 2022 · Cells
Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China
Jing Liu, Zirong Li, Ting Lu, Junping Pan, Li Li, Yanwen Song, Dan Hu, Yanhong Zhuo, Ying Chen, Qin Xu · 2022 · BMC Medical Genomics
Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy
Jinsen Zhang, Rui Sun, Yingying Lyu, Chaxian Liu, Ying Liu, Yuan Feng, Minjie Fu, Peter Jih Cheng Wong, Zunguo Du, Tianming Qiu et al. · 2024 · Nature Communications
AI-driven multi-modal framework for prognostic modeling in glioblastoma: Enhancing clinical decision support
Zihan Zhao, Nguyen Quoc Khanh Le, Matthew Chin Heng Chua · 2025 · Computerized Medical Imaging and Graphics
Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors
Bernarda Majc, Anamarija Habič, Metka Novak, Ana Rotter, Andrej Porčnik, Jernej Mlakar, Vera Župunski, Urša Pečar Fonović, Damijan Knez, Nace Zidar et al. · 2022 · International Journal of Molecular Sciences
Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth
Rossella Delle Donne, Rosa Iannucci, Laura Rinaldi, Luca Roberto, Maria Antonietta Oliva, Emanuela Senatore, Domenica Borzacchiello, Luca Lignitto, Giorgio Giurato, Francesca Maria Rizzo et al. · 2022 · Communications Biology
Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
Ivan Cohen, Fresia G. Pareja, Nicholas D. Socci, Ronglai Shen, Ashley S. Doane, Jazmin Schwartz, Raya Khanin, Elizabeth Ann Morris, Elizabeth Jane Sutton, Ronald G. Blasberg · 2022 · Frontiers in Immunology
Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status
Jakob Maximilian Bader, Nikolaus Deigendesch, Martin Misch, Matthias Mann, Arend Koch, Felix Meissner · 2022 · Cell Reports Medicine
Genetic mutation patterns among glioblastoma patients in the Taiwanese population – insights from a single institution retrospective study
Yu-Fen Huang, Ming‐Tsang Chiao, Tzu‐Hung Hsiao, Yong-Xiang Zhan, Tse‐Yu Chen, Chung-Hsin Lee, Szu-Yuan Liu, Chih‐Hsiang Liao, Wen-Yu Cheng, Chun-Ming Yen et al. · 2024 · Cancer Gene Therapy
Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
Binghao Zhao, Yu Xia, Fengchun Yang, Yaning Wang, Yuekun Wang, Yu Wang, Congxin Dai, Yu Wang, Wenbin Ma · 2022 · Molecular Medicine
Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance
Justine Bailleul, Erina Vlashi · 2023 · Antioxidants and Redox Signaling
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study
Maxime Fontanilles, Jean-David Heisbourg, Arthur Daban, Frédéric Di Fiore, Louis‐Ferdinand Pépin, Florent Marguet, Olivier Langlois, Cristina Alexandru, Isabelle Tennevet, Franklin Ducatez et al. · 2024 · Acta Neuropathologica Communications
Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers
Guo-Sheng Hu, Zao-zao Zheng, Yao-Hui He, Du-chuang Wang, Rui Nie, Wen Liu · 2025 · Molecular & Cellular Proteomics
Network-based identification of key master regulators associated with an immune-silent cancer phenotype
Raghvendra Mall, Mohamad Saad, Jessica P Roelands, Darawan Rinchai, Khalid B. Kunji, Hossam Almeer, Wouter Hendrickx, Francesco Maria Marincola, Michele Ceccarelli, Davide Bedognetti · 2021 · Briefings in Bioinformatics
Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy
Sara Magri, Beatrice Musca, Camilla Bonaudo, Ada Tushe, Maria Giovanna Russo, Elena Masetto, Vittorina Zagonel, Giuseppe Lombardi, Alessandro Della Puppa, Susanna Mandruzzato · 2021 · Cancers
Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
Peng Zhang, Yang Zhang, Nan Ji · 2022 · Frontiers in Immunology
Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies
Nicholas Mikolajewicz, Shahbaz Khan, Mara D. Trifoi, Anna Skakdoub, Vladmir Ignatchenko, Sheila Mansouri, Jeffrey Zuccato, Brad E. Zacharia, Michael Glantz, Gelareh Mohammed Zadeh et al. · 2022 · Neuro-Oncology Advances
Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
Huan Li, Chao Song, Yang Zhang, Guohao Liu, Hailong Mi, Yachao Li, Zhiye Chen, Xiaoyu Ma, Po Zhang, Lidong Cheng et al. · 2023 · Advanced Science
Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment
Milan R. Savani, Mohamad El Shami, Kenji Miki, Lauren C. Gattie, Bailey C. Smith, William Harrison Hicks, Jacob Weiss, Skyler Oken, Lavanya N Katta, Tracey E. Shipman et al. · 2025 · Neuro-Oncology
Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study
Jingxian Duan, Zhenyu Zhang, Yinsheng Chen, Yuanshen Zhao, Qiuchang Sun, Weiwei Wang, Hairong Zheng, Dong Liang, Jingliang Cheng, Jing Yan et al. · 2023 · Molecular Oncology
Mechanistic insight into glioma through spatially multidimensional proteomics
Lei Shen, Zhourui Zhang, Pengfei Wu, Jingyi Yang, Yuankun Cai, Keyu Chen, Songshan Chai, Jingwei Zhao, Hongyu Chen, Xuan Dai et al. · 2024 · Science Advances
Precise Identification of Glioblastoma Micro‐Infiltration at Cellular Resolution by Raman Spectroscopy
Li-jun Zhu, Jianrui Li, Jing Pan, Nan Wu, Qing Xu, Qingqing Zhou, Qiang Wang, Dong Han, Ziyang Wang, Qiang Xu et al. · 2024 · Advanced Science
Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
Rongrong Zhao, Ziwen Pan, Boyan Li, Shulin Zhao, Shouji Zhang, Yanhua Qi, Jiawei Qiu, Zijie Gao, Fan Yang, Qindong Guo et al. · 2022 · Frontiers in Immunology
An ILK/STAT3 pathway controls glioblastoma stem cell plasticity
Alexander E.P. Loftus, Marianna S. Romano, Anh Nguyen Phuong, Ben J McKinnel, Morwenna Muir, Muhammad Furqan, John C. Dawson, Lidia Avalle, Adam Douglas, Richard L. Mort et al. · 2024 · Developmental Cell
Artificial Intelligence Transforming Post-Translational Modification Research
Doo Nam Kim, Tianzhixi Yin, Tong Zhang, Alexandria K Im, J. Cort, Jordan C. Rozum, David D. Pollock, Wei-Jun Qian, Song-Jiang Feng · 2024 · Bioengineering
Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites
Wen Jiang, Eric J. Jaehnig, Yuxing Liao, Zhiao Shi, Tomer M. Yaron, Jared Lee Johnson, Lewis C. Cantley, Bing Zhang · 2025 · Nature Communications
Metabolomic differentiation of tumor core versus edge in glioma
Mary E. Baxter, Hunter A. Miller, Joseph Chen, Brian J. Williams, Hermann B. Frieboes · 2023 · Neurosurgical FOCUS
Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma
Vianney Gilard, Justine Ferey, Florent Marguet, Maxime Fontanilles, Franklin Ducatez, Carine Pilon, Céline Lesueur, Tony Pereira, Carole Basset, Isabelle Schmitz‐Afonso et al. · 2021 · Cancers
Proteomic analysis reveals microvesicles containing NAMPT as mediators of radioresistance in glioma
Elena Panizza, Brandon D. Regalado, Fangyu Wang, Ichiro Nakano, Nathaniel M. Vacanti, Richard A. Cerione, Marc A. Antonyak · 2023 · Life Science Alliance
Discovery of miRNA–mRNA regulatory networks in glioblastoma reveals novel insights into tumor microenvironment remodeling
Iulia A Grigore, Athulram Rajagopal, Jonathan Tak-Sum Chow, T. J. Stone, Leonardo Salmena · 2024 · Scientific Reports
Refinement of prognostication for IDH ‐mutant astrocytomas using DNA methylation‐based classification
Teresia Kling, Sandra Ferreyra Vega, Medha Suman, Anna Dénes, Anna Lipatnikova, Stina Lagerström, Thomas Olsson Bontell, Asgeir Store Jakola, Helena Carén · 2024 · Brain Pathology
Genesis and regulation of C-terminal cyclic imides from protein damage
Wenqing Xu, Zhenguang Zhao, Matthew Su, Atul D. Jain, Hannah C. Lloyd, Ethan Yang Feng, Nick Cox, Christina M. Woo · 2024 · Proceedings of the National Academy of Sciences
A pre-trained large generative model for translating single-cell transcriptomes to proteomes
Linjing Liu, Wei Li, Fang Wang, Yiming Li, Long-Kai Huang, Ka‐Chun Wong, Fan Yang, Jianhua Yao · 2025 · Nature Biomedical Engineering
RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1)
Jianglong Xu, Jia L. Song, Menglin Xiao, Changsheng Wang, Qisong Zhang, Xiaoye Yuan, Shaohui Tian · 2021 · Bioengineered
Aberrant L-Fucose Accumulation and Increased Core Fucosylation Are Metabolic Liabilities in Mesenchymal Glioblastoma
Valentina Pieri, Alberto Luigi Gallotti, Denise Drago, Manuela Cominelli, Ilaria Pagano, Valentina Conti, Silvia Valtorta, Angela Coliva, Sara Lago, Daniela Michelatti et al. · 2022 · Cancer Research
Comprehensive PTM profiling with SCASP-PTM uncovers mechanisms of p62 degradation and ALDOA-mediated tumor progression
Zhan-Peng Lin, Guohong Gan, Xiao Xu, Chengwen Wen, Xin Ding, Xiangyu Chen, Kaijie Zhang, Wenyu Guo, Mingxin Lin, Yu-Yang Wang et al. · 2025 · Cell Reports
Stress-induced pro-inflammatory glioblastoma stem cells secrete TNFAIP6 to enhance tumor growth and induce suppressive macrophages
Danling Gu, Lang Hu, Kailin Yang, Wei Yuan, Danyang Shan, Jiancheng Gao, Jiahuang Li, Ryan C. Gimple, Deobrat Dixit, Zhe Zhu et al. · 2025 · Developmental Cell
NAGS, CPS1, and SLC25A13 (Citrin) at the Crossroads of Arginine and Pyrimidines Metabolism in Tumor Cells
Melissa Owusu-Ansah, Nikita Guptan, Dylon Alindogan, Michio Morizono, Ljubica Caldovic · 2023 · International Journal of Molecular Sciences
Exploring the pan-cancer landscape of posttranscriptional regulation
Umesh Ghoshdastider, Ataman Sendoel · 2023 · Cell Reports
Integration of proteomics in the molecular tumor board
Johanna Thiery, Matthias Fahrner · 2023 · PROTEOMICS
Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging
Ailing He, Peng Wang, Aihua Zhu, Yankui Liu, Jian‐Huan Chen, Li Liu · 2022 · Diagnostics
CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
Guosheng Li, Wei Zhang, Wanying Huang, Rong‐Quan He, Zhi‐Guang Huang, Xiang-Yu Gan, Zhen Yang, Yi‐Wu Dang, Jinliang Kong, Hua‐Fu Zhou et al. · 2023 · BMC Pulmonary Medicine